Authors
Latest:
Low and Maldonado on Leveraging Wearable Devices to Improve Inpatient AmbulationSarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.
Latest:
Oncology Drug Crash Course: Fam-Trastuzumab Deruxtecan-Nxki (Enhertu)After demonstrating significant efficacy as a third-line treatment for patients with metastatic HER2-positive breast cancer, fam-trastuzumab deruxtecan-nxki has gained approval from the FDA for 5 indications and is under investigation across solid tumors.
Latest:
Menstrual Suppression Is a Valuable Component of HSCT Care for Premenopausal WomenMenstrual suppression can improve outcomes and quality of life in premenopausal women undergoing hematopoietic stem cell transplant.
Latest:
Oncology Drug Crash Course: Fam-Trastuzumab Deruxtecan-Nxki (Enhertu)After demonstrating significant efficacy as a third-line treatment for patients with metastatic HER2-positive breast cancer, fam-trastuzumab deruxtecan-nxki has gained approval from the FDA for 5 indications and is under investigation across solid tumors.
Latest:
Insights on Evolving Treatment Strategies for Multiple MyelomaThe panel provides key takeaways on the most impactful innovations shaping the future of multiple myeloma treatment.
Latest:
Adjuvant Mitotane Misses RFS End Point in Adrenocortical CarcinomaAdjuvant mitotane did not yield a significantly reduced risk of recurrence among patients with adrenocortical carcinoma.
Latest:
Normalize the Clinical Trial Conversation"Clinical trials are the vital bridge between research and a drug’s eventual availability to patients."
Latest:
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical CannabisAlyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.
Latest:
MPN-Associated Anemia: What Nurses Should Look Out ForOncology nurses should have open communication with patients and closely monitor their hemoglobin levels when dealing with patients with myelofibrosis who have or may have anemia.
Latest:
Patient Experience Programs Improve Overall Quality of CarePatient experience programs can improve quality of care and decrease organization costs, resulting in a more efficient and less expensive cancer care journey for patients.
Latest:
Advice for New Nurse Practitioners Working With Patients With Endometrial CancerClosing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Latest:
VCU Massey Cancer Center achieves comprehensive status from the National Cancer InstituteVCU Massey Cancer Center has been designated a Comprehensive Cancer Center by the National Cancer Institute (NCI), the nation’s principal authority on cancer research and training.
Latest:
Oncology Drug Crash Course: Olaparib (Lynparza)Olaparib is an oral drug manufactured in 150-mg and 100-mg tablets. Olaparib is taken by mouth, twice daily. It can be taken without or without food.
Latest:
Innovative Program Reduces Nurse Turnover and Fosters DevelopmentThe US Oncology Network (The Network) has developed one of the most comprehensive programs in the nation to support the professional development and retention of new oncology nurses.
Latest:
Cilta-Cel May Outperform Standard Care for Relapsed, Refractory MyelomaAn indirect comparison found that cilta-cel may be better than standard of care for patients with lenalidomise-refractory relapsed/refractory myeloma.
Latest:
FDA Fast Tracks ALE.P02 for CLDN1-Poisitive Solid CancersThe FDA granted a fast track designation to ALE-P02 for patients with CLDN1-positive squamous solid tumors.
Latest:
Advice for New Nurse Practitioners Working With Patients With Endometrial CancerClosing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Latest:
Recipe For DisasterAn oncology social worker reflects on a day in the life and how the memory of her sister motivates her to tackle her work.
Latest:
Psychological Concerns in the Aftermath of a Breast Cancer Diagnosis and Treatment for Young AdultsReceiving a breast cancer diagnosis and undergoing treatment as a young adult takes a physical and emotional toll.
Latest:
Oncology Nurses Can Help Better Prevent Chronic Lymphedema With BIS TechnologySheila Ridner, PhD, RN, FAAN, discusses the implications of the PREVENT study and how oncology nurses can advocate for patients with breast cancer.
Latest:
Cedars-Sinai Launches New Division of Population Sciences ResearchNew Division in the Department of Biomedical Sciences Conducts Translational Research and Engages With Community to Help Reduce the Burden of Disease and Improve Quality of Life.
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Elizabeth Loach on Integrating Frontline Staff in Nursing Task ForcesElizabeth Loach, MSN, APRN, CNS, AGCNS-BC, OCN, discusses the importance of including frontline nurses in nursing leadership task forces.
Latest:
Dispelling Nutrition Myths for Patients With CancerEntering the words nutrition and cancer into Google returns as many as 718 million hits. With an overabundance of opinions, it can be challenging to separate fact from fiction.
Latest:
How I Counsel Patients About Lung Cancer ScreeningA lung cancer screening navigator offers their perspective on shared decision-making.
Latest:
Oncology Drug Crash Course: Olaparib (Lynparza)Olaparib is an oral drug manufactured in 150-mg and 100-mg tablets. Olaparib is taken by mouth, twice daily. It can be taken without or without food.
Latest:
Determining the Cause of Bicytopenia in a Patient With Progressive Dyspnea"Differential diagnoses in patients with bicytopenia—particularly those with preserved platelets—are broad and require careful physical examination."
Latest:
Expert Weighs in on Future of CAR T-Cell Therapy Treatment DirectionsKelly L. Garvin, BSN, RN, OCN, discusses what changes she hopes to see in CAR T-Cell therapy treatment over the coming years.
